Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) operates in the Financial Services sector, specifically the Shell Companies industry, with a market capitalization near $528.8M, listed on NASDAQ, carrying a beta of 0.04 to the broader market. Drugs Made In America Acquisition II Corp. Led by Roger Bendelac, public since 2025-12-04.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for DMII as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.